Author: Bella Hayes
New York, New York–(Newsfile Corp. – December 25, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Silvaco Group, Inc. (NASDAQ: SVCO) resulting from allegations that Silvaco may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Silvaco securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To…
New York, New York–(Newsfile Corp. – December 24, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Light & Wonder, Inc. (NASDAQ: NASDAQ:) resulting from allegations that Light & Wonder may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Light & Wonder securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT…
Vancouver, BC, Dec. 24, 2024 (GLOBE NEWSWIRE) — Demesne Resources Ltd. (CSE:DEME) (OTCQB:DEMRF) (Demesne or the Company) is pleased to announce that it has completed the third tranche (the Third Tranche) of its previously announced non-brokered private placement financing (the Offering). Pursuant to the Third Tranche, the Company issued 1,660,000 common shares of the Company (Common Shares), at a price of $0.25 per Common Share for gross proceeds of approximately $415,000. The Company plans to complete a subsequent tranche of the Offering, for gross proceeds of up to $424,599 in January 2025. In connection with the Third Tranche, the Company…
Lee Ann Gliha, Executive Vice President and Chief Financial Officer of Nexstar Media Group, Inc. (NASDAQ:), recently sold shares of the company’s stock valued at approximately $52,214. The transaction, executed on December 23, involved the sale of 330 shares at an average price of $158.227 per share. The company, currently trading at an attractive 9x P/E ratio, appears undervalued according to InvestingPro analysis, with a “GOOD” overall financial health rating. This sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). On December 20, Gliha acquired 833 shares of common stock through the…
Foxtel, which has transformed into a digital and streaming leader in sports and entertainment content under News Corp (NASDAQ:) management, will join DAZN, a global provider of sports streaming, giving international exposure to Australian sport, while bringing Australian sports fans greater access to programming from across the globeEnterprise value represents more than 7x Fiscal 2024 Foxtel EBITDA, including repayment of shareholder loans amounting to A$706 million and minority equity interest of approximately 9% in DAZN Transaction (JO:) enables News Corp to further simplify to drive long-term stockholder value and increase focus on key growth pillars SYDNEY–(BUSINESS WIRE)–News Corporation (News Corp…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (: FFIE) (FF, Faraday Future, or Company), a California-based technology company specializing in artificial intelligence electric vehicles (AIEV), announced that it has secured approximately $30 million in cash financing commitments. The funds will be used to accelerate the Company’s growth and the development of Faraday X (FX), FF’s strategy of launching affordable high performance AIEV equipped vehicles with cutting edge technology, filling the U.S. market gap in this segment, and for general corporate purposes. Targeting the mainstream EV market in the U.S., FF is expected to have its first two FX prototype mules…
New York, New York–(Newsfile Corp. – December 21, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip…
New York, New York–(Newsfile Corp. – December 20, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aehr Test Systems (NASDAQ: AEHR) between January 9, 2024 and March 24, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Aehr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Aehr class action, go to https://rosenlegal.com/submit-form/?case_id=31986 or call Phillip…
These sales were conducted under a Rule 10b5-1 trading plan, which was adopted on January 4, 2024. As of the latest transaction, Canessa holds 217,423 shares of Zscaler (NASDAQ:) stock. For deeper insights into Zscaler’s valuation metrics and 12 additional exclusive ProTips, visit InvestingPro. For deeper insights into Zscaler’s valuation metrics and 12 additional exclusive ProTips, visit InvestingPro. These sales were conducted under a Rule 10b5-1 trading plan, which was adopted on January 4, 2024. As of the latest transaction, Canessa holds 217,423 shares of Zscaler stock. For deeper insights into Zscaler’s valuation metrics and 12 additional exclusive ProTips, visit…
Douglas B. Given, a director at Arrowhead Pharmaceuticals, Inc. (NASDAQ:), reported selling shares of common stock valued at approximately $121,555, according to a recent SEC filing. The transactions occurred on December 16 and 17, with shares sold at prices ranging from $21.90 to $22.04. The stock has since declined to $20.36, with InvestingPro analysis indicating the company is currently overvalued. With a market capitalization of $2.56 billion, Arrowhead faces some financial challenges, as highlighted by its “Weak” overall financial health score. Following these sales, Given holds 124,167 shares of the company. The sales were part of a pre-established 10b5-1 trading…
